Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 600

1.

Correction of Motion Artifacts Using a Multiscale Fully Convolutional Neural Network.

Sommer K, Saalbach A, Brosch T, Hall C, Cross NM, Andre JB.

AJNR Am J Neuroradiol. 2020 Mar;41(3):416-423. doi: 10.3174/ajnr.A6436. Epub 2020 Feb 13.

PMID:
32054615
2.

Treatment-free remission in FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation.

Metzgeroth G, Schwaab J, Naumann N, Jawhar M, Haferlach T, Fabarius A, Hochhaus A, Hofmann WK, Cross NCP, Reiter A.

Blood Adv. 2020 Feb 11;4(3):440-443. doi: 10.1182/bloodadvances.2019001111.

3.

The voice of the radiologist: Enabling patients to speak directly to radiologists.

Cross NM, Wildenberg J, Liao G, Novak S, Bevilacqua T, Chen J, Siegelman E, Cook TS.

Clin Imaging. 2020 May;61:84-89. doi: 10.1016/j.clinimag.2019.09.014. Epub 2019 Nov 28.

PMID:
31986355
4.

Memory Performance Correlates of Hippocampal Subfield Volume in Mild Cognitive Impairment Subtype.

Broadhouse KM, Mowszowski L, Duffy S, Leung I, Cross N, Valenzuela MJ, Naismith SL.

Front Behav Neurosci. 2019 Nov 21;13:259. doi: 10.3389/fnbeh.2019.00259. eCollection 2019.

5.

Nocturnal Hypoxemia Is Associated with Altered Parahippocampal Functional Brain Connectivity in Older Adults at Risk for Dementia.

Naismith SL, Duffy SL, Cross N, Grunstein R, Terpening Z, Hoyos C, D'Rozario A, Lagopoulos J, Osorio RS, Shine JM, McKinnon AC.

J Alzheimers Dis. 2020;73(2):571-584. doi: 10.3233/JAD-190747.

PMID:
31815696
6.

Brain Rhythms During Sleep and Memory Consolidation: Neurobiological Insights.

Marshall L, Cross N, Binder S, Dang-Vu TT.

Physiology (Bethesda). 2020 Jan 1;35(1):4-15. doi: 10.1152/physiol.00004.2019. Erratum in: Physiology (Bethesda). 2020 Mar 1;35(2):157.

PMID:
31799908
7.

Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet.

Itzykson R, Fenaux P, Bowen D, Cross NCP, Cortes J, De Witte T, Germing U, Onida F, Padron E, Platzbecker U, Santini V, Sanz GF, Solary E, Van de Loosdrecht A, Malcovati L.

Hemasphere. 2018 Nov 29;2(6):e150. doi: 10.1097/HS9.0000000000000150. eCollection 2018 Dec.

8.

JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera.

Patel AB, Franzini A, Leroy E, Kim SJ, Pomicter AD, Genet L, Xiao M, Yan D, Ahmann JM, Agarwal AM, Clair P, Addada J, Lambert J, Salmon M, Gleich GJ, Cross NCP, Constantinescu SN, O'Hare T, Prchal JT, Deininger MW.

Blood. 2019 Dec 26;134(26):2388-2398. doi: 10.1182/blood.2019001385.

PMID:
31697804
9.

Mass spectrometry imaging of endogenous metabolites in response to doxorubicin in a novel 3D osteosarcoma cell culture model.

Palubeckaitė I, Crooks L, Smith DP, Cole LM, Bram H, Le Maitre C, Clench MR, Cross NA.

J Mass Spectrom. 2019 Oct 26. doi: 10.1002/jms.4461. [Epub ahead of print]

PMID:
31654532
10.

Authors' Reply.

Wong G, Hope RL, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Turner R, Williams G, Lim WH, Lok CE, Diekman F, Cross N, Sen S, Allen RDM, Chadban SJ, Pollock CA, Tong A, Teixeira-Pinto A, Yang JYH, Williams N, Au E, Kieu A, James L, Craig JC.

J Am Soc Nephrol. 2019 Nov;30(11):2276-2277. doi: 10.1681/ASN.2019090889. Epub 2019 Oct 9. No abstract available.

PMID:
31597717
11.

The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib.

O'Sullivan JM, Hamblin A, Yap C, Fox S, Boucher R, Panchal A, Alimam S, Dreau H, Howard K, Ware P, Cross NCP, McMullin MF, Harrison CN, Mead AJ.

Blood. 2019 Dec 5;134(23):2107-2111. doi: 10.1182/blood.2019001861. No abstract available.

12.

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis.

Jawhar M, Schwaab J, Álvarez-Twose I, Shoumariyeh K, Naumann N, Lübke J, Perkins C, Muñoz-González JI, Meggendorfer M, Kennedy V, Metzgeroth G, Fabarius A, Pfeifer D, Sotlar K, Horny HP, von Bubnoff N, Haferlach T, Cross NCP, Hofmann WK, Sperr WR, García-Montero AC, Valent P, Gotlib J, Orfao A, Reiter A.

J Clin Oncol. 2019 Nov 1;37(31):2846-2856. doi: 10.1200/JCO.19.00640. Epub 2019 Sep 11.

PMID:
31509472
13.

TRAIL responses are enhanced by nuclear export inhibition in osteosarcoma.

Phillips KL, Wright N, McDermott E, Cross NA.

Biochem Biophys Res Commun. 2019 Sep 17;517(2):383-389. doi: 10.1016/j.bbrc.2019.07.047. Epub 2019 Jul 27.

PMID:
31362889
14.

Polyphenols enhance the activity of alkylating agents in leukaemia cell lines.

Mahbub AA, Maitre CLL, Haywood-Small S, Cross NA, Jordan-Mahy N.

Oncotarget. 2019 Jul 16;10(44):4570-4586. doi: 10.18632/oncotarget.27068. eCollection 2019 Jul 16.

15.

Assessment of need for lower level acuity critical care services at a tertiary acute care hospital in Canada: A prospective cohort study.

Haun de Oliveira O, Pinto R, DasGupta T, Sirtartchouck L, Rashleigh L, Cross N, Srikandarajah A, Sukumaran J, Wunsch H, Cuthbertson BH.

J Crit Care. 2019 Oct;53:91-97. doi: 10.1016/j.jcrc.2019.06.004. Epub 2019 Jun 4.

PMID:
31202164
16.

Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on Aging.

Cross NE, Carrier J, Postuma RB, Gosselin N, Kakinami L, Thompson C, Chouchou F, Dang-Vu TT.

Sleep. 2019 Aug 1;42(8). pii: zsz114. doi: 10.1093/sleep/zsz114.

PMID:
31089710
17.

A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature.

Levavi H, Tripodi J, Marcellino B, Mascarenhas J, Jones AV, Cross NCP, Gruenstein D, Najfeld V.

Acta Haematol. 2019;142(2):105-112. doi: 10.1159/000498945. Epub 2019 May 7. Review.

18.

One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).

Wong G, Hope RL, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Turner R, Williams G, Lim WH, Lok CE, Diekmann F, Cross NB, Sen S, Allen RDM, Chadban SJ, Pollock CA, Tong A, Teixeira-Pinto A, Yang JYH, Williams N, Au EHK, Kieu A, James L, Craig JC.

J Am Soc Nephrol. 2019 Jun;30(6):1061-1072. doi: 10.1681/ASN.2018121232. Epub 2019 Apr 30.

PMID:
31040191
19.

Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry).

Möbius S, Schenk T, Himsel D, Maier J, Franke GN, Saussele S, Pott C, Andrikovics H, Meggyesi N, Machova-Polakova K, Zizkova H, Jurcek T, Mesanovic S, Zadro R, Gottardi E, Haenig J, Schuld P, Cross NCP, Hochhaus A, Ernst T.

J Cancer Res Clin Oncol. 2019 Jun;145(6):1645-1650. doi: 10.1007/s00432-019-02910-6. Epub 2019 Apr 2.

PMID:
30941573
20.

Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosis.

Lübke J, Naumann N, Kluger S, Schwaab J, Metzgeroth G, Evans E, Gardino AK, Lengauer C, Hofmann WK, Fabarius A, Cross NCP, Reiter A, Jawhar M.

Leukemia. 2019 May;33(5):1195-1205. doi: 10.1038/s41375-019-0450-8. Epub 2019 Mar 25.

21.

Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission.

White SL, Rawlinson W, Boan P, Sheppeard V, Wong G, Waller K, Opdam H, Kaldor J, Fink M, Verran D, Webster A, Wyburn K, Grayson L, Glanville A, Cross N, Irish A, Coates T, Griffin A, Snell G, Alexander SI, Campbell S, Chadban S, Macdonald P, Manley P, Mehakovic E, Ramachandran V, Mitchell A, Ison M.

Transplant Direct. 2018 Dec 20;5(1):e416. doi: 10.1097/TXD.0000000000000852. eCollection 2019 Jan.

22.

KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis.

Jawhar M, Döhner K, Kreil S, Schwaab J, Shoumariyeh K, Meggendorfer M, Span LLF, Fuhrmann S, Naumann N, Horny HP, Sotlar K, Kubuschok B, von Bubnoff N, Spiekermann K, Heuser M, Metzgeroth G, Fabarius A, Klein S, Hofmann WK, Kluin-Nelemans HC, Haferlach T, Döhner H, Cross NCP, Sperr WR, Valent P, Reiter A.

Leukemia. 2019 May;33(5):1124-1134. doi: 10.1038/s41375-018-0346-z. Epub 2019 Jan 11.

23.

Molecular response to imatinib in KIT F522C-mutated systemic mastocytosis.

Broderick V, Waghorn K, Langabeer SE, Jeffers M, Cross NCP, Hayden PJ.

Leuk Res. 2019 Feb;77:28-29. doi: 10.1016/j.leukres.2018.12.010. Epub 2018 Dec 24. No abstract available.

PMID:
30612056
24.

PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia.

Chase A, Pellagatti A, Singh S, Score J, Tapper WJ, Lin F, Hoade Y, Bryant C, Trim N, Yip BH, Zoi K, Rasi C, Forsberg LA, Dumanski JP, Boultwood J, Cross NCP.

Leukemia. 2019 May;33(5):1184-1194. doi: 10.1038/s41375-018-0340-5. Epub 2018 Dec 20.

25.

Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.

Cross NCP, Hoade Y, Tapper WJ, Carreno-Tarragona G, Fanelli T, Jawhar M, Naumann N, Pieniak I, Lübke J, Ali S, Bhuller K, Burgstaller S, Cargo C, Cavenagh J, Duncombe AS, Das-Gupta E, Evans P, Forsyth P, George P, Grimley C, Jack F, Munro L, Mehra V, Patel K, Rismani A, Sciuccati G, Thomas-Dewing R, Thornton P, Virchis A, Watt S, Wallis L, Whiteway A, Zegocki K, Bain BJ, Reiter A, Chase A.

Leukemia. 2019 Feb;33(2):415-425. doi: 10.1038/s41375-018-0342-3. Epub 2018 Dec 20.

26.

Compressed Sensing-Sensitivity Encoding (CS-SENSE) Accelerated Brain Imaging: Reduced Scan Time without Reduced Image Quality.

Vranic JE, Cross NM, Wang Y, Hippe DS, de Weerdt E, Mossa-Basha M.

AJNR Am J Neuroradiol. 2019 Jan;40(1):92-98. doi: 10.3174/ajnr.A5905. Epub 2018 Dec 6.

27.

A forward genetic screen reveals a primary role for Plasmodium falciparum Reticulocyte Binding Protein Homologue 2a and 2b in determining alternative erythrocyte invasion pathways.

Campino S, Marin-Menendez A, Kemp A, Cross N, Drought L, Otto TD, Benavente ED, Ravenhall M, Schwach F, Girling G, Manske M, Theron M, Gould K, Drury E, Clark TG, Kwiatkowski DP, Pance A, Rayner JC.

PLoS Pathog. 2018 Nov 29;14(11):e1007436. doi: 10.1371/journal.ppat.1007436. eCollection 2018 Nov.

28.

Avoiding MRI-Related Accidents: A Practical Approach to Implementing MR Safety.

Cross NM, Hoff MN, Kanal KM.

J Am Coll Radiol. 2018 Dec;15(12):1738-1744. doi: 10.1016/j.jacr.2018.06.022. Epub 2018 Aug 24.

PMID:
30149951
29.

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK.

Cross NCP, White HE, Evans PAS, Hancock J, Copland M, Milojkovic D, Mason J, Craine S, Mead AJ.

Br J Haematol. 2018 Sep;182(6):777-788. doi: 10.1111/bjh.15542. Epub 2018 Aug 20. Review.

30.

Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer.

McKenzie HS, Mead G, Huddart R, White JD, Rustin GJS, Hennig IM, Cozens K, Cross N, Bowers M, Wheater MJ.

Clin Genitourin Cancer. 2018 Dec;16(6):458-465.e2. doi: 10.1016/j.clgc.2018.07.006. Epub 2018 Jul 17.

PMID:
30115544
31.

Structural brain correlates of obstructive sleep apnoea in older adults at risk for dementia.

Cross NE, Memarian N, Duffy SL, Paquola C, LaMonica H, D'Rozario A, Lewis SJG, Hickie IB, Grunstein RR, Naismith SL.

Eur Respir J. 2018 Jul 4;52(1). pii: 1800740. doi: 10.1183/13993003.00740-2018. Print 2018 Jul.

32.

Practical CT Dose Monitoring: Current Tools and the Clinical Relevance.

Cross NM, Zamora DA, Moirano JM, Hoff MN, Kanal KM.

Semin Roentgenol. 2018 Apr;53(2):115-123. doi: 10.1053/j.ro.2018.02.002. Epub 2018 Feb 6. Review. No abstract available.

PMID:
29861003
33.

Absence of CALR Mutations in Idiopathic Erythrocytosis Patients with Low Serum Erythropoietin Levels.

Catherwood MA, Graham A, Cuthbert RJG, Garrec C, Gardie B, Girodon F, Laird S, Cross NCP, McMullin MF.

Acta Haematol. 2018;139(4):217-219. doi: 10.1159/000489006. Epub 2018 May 30. No abstract available.

PMID:
29847812
34.

An in vitro erythrocyte preference assay reveals that Plasmodium falciparum parasites prefer Type O over Type A erythrocytes.

Theron M, Cross N, Cawkill P, Bustamante LY, Rayner JC.

Sci Rep. 2018 May 25;8(1):8133. doi: 10.1038/s41598-018-26559-2.

35.

IoT in Radiology: Using Raspberry Pi to Automatically Log Telephone Calls in the Reading Room.

Chen PH, Cross N.

J Digit Imaging. 2018 Jun;31(3):371-378. doi: 10.1007/s10278-018-0081-z. Review.

36.

Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial.

Papp KA, Merola JF, Gottlieb AB, Griffiths CEM, Cross N, Peterson L, Cioffi C, Blauvelt A.

J Am Acad Dermatol. 2018 Aug;79(2):277-286.e10. doi: 10.1016/j.jaad.2018.03.037. Epub 2018 Mar 30.

37.

Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains.

Feng G, Boyle MJ, Cross N, Chan JA, Reiling L, Osier F, Stanisic DI, Mueller I, Anders RF, McCarthy JS, Richards JS, Beeson JG.

J Infect Dis. 2018 Jun 5;218(1):35-43. doi: 10.1093/infdis/jiy170.

38.

Feature extraction via similarity search: application to atom finding and denoising in electron and scanning probe microscopy imaging.

Somnath S, Smith CR, Kalinin SV, Chi M, Borisevich A, Cross N, Duscher G, Jesse S.

Adv Struct Chem Imaging. 2018;4(1):3. doi: 10.1186/s40679-018-0052-y. Epub 2018 Mar 1.

39.

Quantity Over Quality: Metrics in Solid Organ Transplantation.

Cross NB, Dittmer I.

Transplantation. 2018 Jul;102(7):1031-1032. doi: 10.1097/TP.0000000000002150. No abstract available.

PMID:
29485509
40.

Chronic neutrophilic leukemia.

Khoder A, Al Obaidi M, Babb A, Liu C, Cross NCP, Bain BJ.

Am J Hematol. 2018 Jun;93(6):841-842. doi: 10.1002/ajh.25073. Epub 2018 Mar 14. No abstract available.

41.

Routine Screening for KIT M541L Is Not Warranted in the Diagnostic Work-Up of Patients with Hypereosinophilia.

Hoade Y, Metzgeroth G, Schwaab J, Reiter A, Cross NCP.

Acta Haematol. 2018;139(2):71-73. doi: 10.1159/000485959. Epub 2018 Jan 26. No abstract available.

PMID:
29393093
42.

Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis.

Naumann N, Jawhar M, Schwaab J, Kluger S, Lübke J, Metzgeroth G, Popp HD, Khaled N, Horny HP, Sotlar K, Valent P, Haferlach C, Göhring G, Schlegelberger B, Meggendorfer M, Hofmann WK, Cross NCP, Reiter A, Fabarius A.

Genes Chromosomes Cancer. 2018 May;57(5):252-259. doi: 10.1002/gcc.22526. Epub 2018 Feb 19.

PMID:
29341334
43.

Dietary polyphenols influence antimetabolite agents: methotrexate, 6-mercaptopurine and 5-fluorouracil in leukemia cell lines.

Mahbub A, Le Maitre C, Haywood-Small S, Cross N, Jordan-Mahy N.

Oncotarget. 2017 Aug 24;8(62):104877-104893. doi: 10.18632/oncotarget.20501. eCollection 2017 Dec 1.

44.

A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5).

Ghazzawi M, Mehra V, Knut M, Brown L, Tapper W, Chase A, de Lavallade H, Cross NCP.

Acta Haematol. 2017;138(4):198-200. doi: 10.1159/000484077. Epub 2017 Nov 24. No abstract available.

45.

Synergistic malaria vaccine combinations identified by systematic antigen screening.

Bustamante LY, Powell GT, Lin YC, Macklin MD, Cross N, Kemp A, Cawkill P, Sanderson T, Crosnier C, Muller-Sienerth N, Doumbo OK, Traore B, Crompton PD, Cicuta P, Tran TM, Wright GJ, Rayner JC.

Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):12045-12050. doi: 10.1073/pnas.1702944114. Epub 2017 Oct 23.

46.

Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.

Harrison CN, Mead AJ, Panchal A, Fox S, Yap C, Gbandi E, Houlton A, Alimam S, Ewing J, Wood M, Chen F, Coppell J, Panoskaltsis N, Knapper S, Ali S, Hamblin A, Scherber R, Dueck AC, Cross NCP, Mesa R, McMullin MF.

Blood. 2017 Oct 26;130(17):1889-1897. doi: 10.1182/blood-2017-05-785790. Epub 2017 Aug 9.

47.

Deceased donor kidney transplantation in New Zealand: use and audit of a survival prediction tool.

Dowen F, Cross N, Clayton P, Pilmore H.

N Z Med J. 2017 Oct 27;130(1464):33-39.

PMID:
29073655
48.

Phenotypic Plasticity in Uveal Melanoma Is Not Restricted to a Tumor Subpopulation and Is Unrelated to Cancer Stem Cell Characteristics.

Doherty RE, Sisley K, Hammond DW, Rennie IG, Cross NA.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5387-5395. doi: 10.1167/iovs.17-22272.

49.

SAHA-induced TRAIL-sensitisation of Multiple Myeloma cells is enhanced in 3D cell culture.

Arhoma A, Chantry AD, Haywood-Small SL, Cross NA.

Exp Cell Res. 2017 Nov 15;360(2):226-235. doi: 10.1016/j.yexcr.2017.09.012. Epub 2017 Sep 8.

PMID:
28890292
50.

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.

Yip BH, Steeples V, Repapi E, Armstrong RN, Llorian M, Roy S, Shaw J, Dolatshad H, Taylor S, Verma A, Bartenstein M, Vyas P, Cross NC, Malcovati L, Cazzola M, Hellström-Lindberg E, Ogawa S, Smith CW, Pellagatti A, Boultwood J.

J Clin Invest. 2017 Sep 1;127(9):3557. doi: 10.1172/JCI96202. Epub 2017 Sep 1. No abstract available.

Supplemental Content

Support Center